Ai Mediq is a Luxembourg-based ground-breaking medical technology company that develops novel non-invasive therapeutic solutions leveraging positive treatment effects of high altitude (hypoxic) exposure, medical devices for Intermittent Hypoxic Treatment, and medical software algorithms for its personalisation.
Ai Mediq is the first company in the world which commercialised the idea of using physiological effects of adaptation to short term episodes of hypoxia for clinical treatment purposes.
Aimediq Asia Pte Ltd serves as the Asia headquarters, based in Singapore, responsible for managing the distribution, training, technical support services, sales, and marketing of Aimediq’s cutting-edge products, devices, and accessories across the Asia Pacific region.
Mission
At Aimediq Asia, our mission is clear – to lead the industry, creating value for all key stakeholders, while continuously increasing our market share. We are committed to building strong brand equity and making a positive impact through innovative and professional business management.
We envision the products distributed by Aimediq Asia Pte Ltd to be trusted and esteemed premium brands. We strive to make them the essential and must-have devices in various industries, reflecting our dedication to delivering excellence.
Join us on this journey towards excellence, as we endeavor to become a driving force in the industry, empowering professionals with the most advanced and reliable medical solutions.
Vision